Understanding how immune cells affect pregnancy and protect against infections.

Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission

['FUNDING_R01'] · WEILL MEDICAL COLL OF CORNELL UNIV · NIH-11049013

This study is looking at how special immune cells called natural killer (NK) cells help keep both mom and baby healthy during pregnancy, especially in fighting off infections like cytomegalovirus (CMV), and it’s for anyone interested in understanding more about how the body protects the fetus while allowing it to grow.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorWEILL MEDICAL COLL OF CORNELL UNIV (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-11049013 on ClinicalTrials.gov

What this research studies

This research investigates the role of natural killer (NK) cells at the maternal-fetal interface during pregnancy. It aims to understand how these immune cells help maintain pregnancy while also protecting the fetus from infections like cytomegalovirus (CMV). The study utilizes both human samples and a nonhuman primate model to explore the dynamics of these immune cells throughout different stages of pregnancy. By examining the interactions between maternal NK cells and the fetus, the research seeks to fill gaps in knowledge regarding fetal tolerance and pathogen defense.

Who could benefit from this research

Good fit: Ideal candidates for this research include pregnant individuals, particularly those with a history of cytomegalovirus infection or complications during pregnancy.

Not a fit: Patients who are not pregnant or those without any history of immune-related pregnancy complications may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing congenital infections and adverse pregnancy outcomes.

How similar studies have performed: Other research has shown promising results in understanding immune cell functions during pregnancy, but this specific focus on NK cells and CMV transmission is relatively novel.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.